APA (7th ed.) Citation

Mega, J. L., Hochholzer, W., Frelinger, A. L., Kluk, M. J., Angiolillo, D. J., Kereiakes, D. J., . . . Sabatine, M. S. (2011). Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease. JAMA : the journal of the American Medical Association, 306(20), 2221-2228. https://doi.org/10.1001/jama.2011.1703

Chicago Style (17th ed.) Citation

Mega, Jessica L., et al. "Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease." JAMA : The Journal of the American Medical Association 306, no. 20 (2011): 2221-2228. https://doi.org/10.1001/jama.2011.1703.

MLA (9th ed.) Citation

Mega, Jessica L., et al. "Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease." JAMA : The Journal of the American Medical Association, vol. 306, no. 20, 2011, pp. 2221-2228, https://doi.org/10.1001/jama.2011.1703.